Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SITAGLIPTIN Cause C-reactive protein increased? 19 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 19 reports of C-reactive protein increased have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.1% of all adverse event reports for SITAGLIPTIN.

19
Reports of C-reactive protein increased with SITAGLIPTIN
0.1%
of all SITAGLIPTIN reports
1
Deaths
15
Hospitalizations

How Dangerous Is C-reactive protein increased From SITAGLIPTIN?

Of the 19 reports, 1 (5.3%) resulted in death, 15 (78.9%) required hospitalization, and 1 (5.3%) were considered life-threatening.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 19 reports have been filed with the FAERS database.

What Other Side Effects Does SITAGLIPTIN Cause?

Blood glucose increased (1,427) Pancreatic carcinoma (1,142) Product dose omission issue (1,125) Drug ineffective (1,057) No adverse event (994) Nausea (936) Pancreatitis (922) Diabetes mellitus inadequate control (744) Diarrhoea (712) Hypoglycaemia (674)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) LEFLUNOMIDE (3,574) HYDROXYCHLOROQUINE (3,552) ABATACEPT (3,451) SULFASALAZINE (3,096)

Which SITAGLIPTIN Alternatives Have Lower C-reactive protein increased Risk?

SITAGLIPTIN vs SOAP SITAGLIPTIN vs SODIUM SITAGLIPTIN vs SODIUM BICARBONATE SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM SITAGLIPTIN vs SODIUM BORATE

Related Pages

SITAGLIPTIN Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased SITAGLIPTIN Demographics